Search Constraints
Search Results
Select an image to start the slideshow
Molecular Basis of NMDA Receptor Allosteric Regulation by New
Subunit-selective Modulators
1 of 26
Identifying Novel Therapeutic Strategies for Enhancing Social
Cognition Using Functional Animal Models
2 of 26
Stereospecificity of the prosocial and neurotoxic effects of
3,4-methylenedioxymethamphetamine (MDMA) in mice
3 of 26
Comprehensive Proteome and Transcriptome Studies Reveal RNA
Processing Dysfunction in Alzheimer's disease
4 of 26
The long-term effects of prenatal stress and/or antidepressant
exposure in rats
5 of 26
Discovery and Development of Selective M1 Agonists
that Protect Against Alzheimer's Pathology and Bias Hippocampal
Circuitry Dynamics in Rodents
6 of 26
Role of 3' untranslated regions in translation regulation of
GluR2 mRNAs
7 of 26
Investigating the Effects of Specific Acetylcholine Receptor
Activation on Hippocampal Function for the Treatment of Alzheimer's
Disease
8 of 26
Activation and regulation of the brain-expressed adhesion G
protein-coupled receptors ADGRB1/BAI1 and ADGRB2/BAI2: Implications
for human disease
9 of 26
Reduced vesicular storage of catecholamines in the pathogenesis of
Parkinson's Disease
10 of 26
Microglial motility under pro-inflammatory conditions in situ:
Relevance to neurodegeneration
11 of 26
Examination of Phasic and Sustained Fear Responses Using a Novel
Sustained Fear Conditioning Paradigm
12 of 26
Neurochemical, neuroprotective, and behavioral effects of enhanced
vesicular storage of dopamine
13 of 26
The Role of RGS14 in Learning, Memory, and Synaptic Plasticity
14 of 26
Trafficking and Signaling of Parkin-AssociatedEndothelin-Like Receptor GPR37
15 of 26
The Transitional States of Drug Addiction in Rhesus Monkeys
16 of 26
Cortical mechanisms and developmental contributions to habit formation
17 of 26
Therapeutic effect of Berberine on Huntington's Disease Transgenic Mouse Model
18 of 26
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
19 of 26
In Vivo Investigation of Escitalopram's Allosteric Site on the Serotonin Transporter
20 of 26
Factors that modulate Ca2+-dependent regulation ofCav2.1 (P/Q-type) Ca2+ channels
21 of 26
Abnormal Recovery from Anesthesia: A Marker of Early Cognitive Dysfunction in Rodent Models of Disease
22 of 26
Investigating the Role of the Pre-M1 Helix and Other Highly Conserved Regions in NMDA Receptor Function
23 of 26
Synthesis, Structure-Activity Relationship, and Biological Evaluation of Subunit-Selective NMDA Receptor Modulators
24 of 26
GluN2B-Selective NMDA Receptor Negative Allosteric Modulation as a Treatment for Chronic Pain and Opioid Tolerance
25 of 26
Elucidating the Lysosomal Function of Granulins
26 of 26